Treatment of organic personality syndrome with low-dose trazodone
Tejera, C.A.; Saravay, S.M.
Journal of Clinical Psychiatry 56(8): 374-375
1995
ISSN/ISBN: 0160-6689 PMID: 7635856 Document Number: 449969
Document emailed within 1 workday
Related Documents
Sánchez, P.; Quemada, J.I. 2000: Organic personality disorder. Conceptual and diagnostic aspects Revista de Neurologia 30(8): 772-778Quemada, J.I.; Sánchez-Cubillo, I.; Muñoz-Céspedes, J.M. 2007: Organic personality disorder: conceptual review and research strategies Actas Espanolas de Psiquiatria 35(2): 115-121
Jovicić, A.; Miljanović, B.; Preradović, M.; Nikić, S. 1979: Use of Kalicor in the treatment of psycho-organic syndrome Vojnosanitetski Pregled 36(4): 284-286
Roccatagliata, G.; Gandolfo, C.; Cammarata, S.; De Martini, I.; Arcuri, T. 1979: Treatment of depression in the menopause with trazodone La Clinica Terapeutica 91(1): 67-72
Gałecki, P.; Florkowski, A. 2010: Effectiveness of trazodone in the treatment of sexual dysfunctions Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 29(169): 66-69
Andréjak, M.; Zannad, Fïez.; Laville, M.; Duru, Gérard.; Mourad, J-Jacques.; Waeber, B. 2003: Evaluation of different approaches to the treatment of arterial hypertension: combination treatment with low dose perindopril/indapamide versus sequential treatment of stepped-dose treatment Therapie 58(4): 351-352
Funk, S.án. 2013: Pharmacological treatment in alcohol-, drug- and benzodiazepine-dependent patients - the significance of trazodone Neuropsychopharmacologia Hungarica: a Magyar Pszichofarmakologiai Egyesulet Lapja 15(2): 85-93
Wichniak, A.; Wierzbicka, A.; Sobańska, A.; Szatkowska, E.; Czasak, K.; Musińska, I.; Jernajczyk, W. 2007: The effectiveness of treatment with trazodone in patients with primary insomnia without and with prior history of hypnotics use Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 23(133): 41-46
Wada, S.; Isono, C.; Ogawa, K. 1981: The dose of nicorandil in men predicted from the inhibition of MAO activity by organic nitrates Arzneimittel-Forschung 31(10): 1685-1687
Waage, A.; Hammerstrøm, J.; Lødemel, B.; Hoff, J.E.; Langtind, J. 1986: Myelodysplastic syndrome and myelogenous leukemia. Treatment with low-dose cytarabine Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 106(6): 496-497
Termeer, C.C.; Simon, J.C.; Schöpf, E. 2001: Low-dose interferon alfa-2b for the treatment of Churg-Strauss syndrome with prominent skin involvement Archives of Dermatology 137(2): 136-138
Kamei, T.; Nakagawa, H.; Uchiyama, F.; Fukuyama, J. 1993: Treatment of Guillain-Barré syndrome with high-dose intravenous immunoglobulins--a comparison with plasma exchange Rinsho Shinkeigaku 33(6): 660-662
Tsai, M-Chang.; Huang, T-Lai. 2010: Severe neuroleptic malignant syndrome: successful treatment with high-dose lorazepam and diazepam: a case report Chang Gung Medical Journal 33(5): 576-580
Ueda, T.; Tohyama, K.; Wano, Y.; Tsutani, H.; Fukushima, T.; Iwasaki, H.; Urasaki, Y.; Gotoh, N.; Kimura, S.; Okumura, E. 1994: Pharmacokinetic and clinical pilot study of high-dose intermittent ubenimex treatment in patients with myelodysplastic syndrome Anticancer Research 14(5b): 2093-2097
Gibbs, M.V.; Thorpe, J.G. 1983: Personality stereotype of noninstitutionalized Down syndrome children American Journal of Mental Deficiency 87(6): 601-605
Westling, S.; Ramklint, M. 2016: Self-injurious behavior is common also without personality syndrome Lakartidningen 113
Fallschüssel, G.K. 1983: Personality profile and personality development of patients with functional disorders of the masticatory system Deutsche Zahnarztliche Zeitschrift 38(7): 670-674
Smulevich, A.B.; Volel', B.A. 2008: Personality disorders and somatic diseases (the problem of hypochondrical development of personality) Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 108(5): 4-12
Zahn, P.; Jackowski, M.; Fischer, J. 1989: Personality markers in patients with sleep apnea syndrome Pneumologie 43(Suppl 1): 630-634
Nakauchi, M. 1972: Analysis of personality formation of children affected with Down's syndrome Seishin Shinkeigaku Zasshi 74(2): 79-97